Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case–control study
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cardiovascular diseases are associated with disturbances in calcium metabolism, including increased urinary calcium, vitamin D insufficiency, and decreased bone mineral density. Antihypertensive drugs may increase the risk of falling. However, risk of fracture in patients treated with non-diuretic cardiovascular drugs is largely unknown. AIM: We investigated associations between fracture risk and treatment with commonly used cardiovascular drugs: beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, and calcium-channel blockers. DESIGN: A population-based pharmaco-epidemiological case-control study with fracture in year 2000 as outcome and drug use during the previous 5 years as exposure. We used nationwide computerized registers to assess individual use of drugs and related these data to individual fracture records and information on socio-economic and health-related confounders. RESULTS: We included 124,655 cases that sustained a fracture and 373,962 age and gender-matched controls. After adjustment for potential confounders, risk of any fracture was reduced by 9% [odds ratio (OR) 0.91; 95% confidence interval (CI), 0.88-0.93] in users of beta-blockers, by 6% (OR, 0.94; 95%CI, 0.91-0.96) in users of calcium-channel blockers, and by 7% (OR, 0.93; 95%CI, 0.90-0.96) in users of ACE inhibitors. Moreover, risk of hip fractures was reduced significantly by 7-14% in users of the three groups of drugs. No major differences were found between men and women or in subjects younger or older than 70 years of age. Sub-analyses indicated differences between groups of calcium-channel blockers, as use of non-dihydropyridine drugs was associated with a larger risk reduction than use of dihydropyridine drugs. CONCLUSION: Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a small but significantly reduced risk of fracture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
The Danish National Hospital Register. A valuable source of data for modern health sciences.
Andersen, T. F., Madsen, M., Jørgensen, J. O. L., Mellemkjoer, L., & Olsen, J. H. (1999) · PubMed · Cited by 2,026
How to measure comorbiditya critical review of available methods
DEGROOT, V, BECKERMAN, H., LANKHORST, G., & BOUTER, L. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00585-1 · Cited by 1,757
Leptin Regulates Bone Formation via the Sympathetic Nervous System
Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P., & Karsenty, G. (2002) · Cell · doi:10.1016/s0092-8674(02)01049-8 · Cited by 1,735
Selection of Controls in Case-Control Studies
Wacholder, S., McLaughlin, J. K., Silverman, D. T., & Mandel, J. S. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116396 · Cited by 998
Mosekilde, L. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02226.x · Cited by 417
Self-citationHigh blood pressure and bone-mineral loss in elderly white women: a prospective study
Cappuccio, F. P., Meilahn, E., Zmuda, J. M., & Cauley, J. A. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01437-3 · Cited by 369
Use of β-Blockers and Risk of Fractures
Schlienger, R. G. (2004) · JAMA · doi:10.1001/jama.292.11.1326 · Cited by 343
Vestergaard, P. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf007 · Cited by 321
Self-citationPasco, J. A., Henry, M. J., Sanders, K. M., Kotowicz, M. A., Seeman, E., & Nicholson, G. C. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301214 · Cited by 260
Togari, A. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10121 · Cited by 213
Alcohol Intake, Beverage Preference, and Risk of Hip Fracture in Men and Women
Hoidrup, S., Gronbaek, M., Gottschau, A., Lauritzen, J. B., Schroll, M., & Copenhagen Centre for Prospective Population Studies (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009760 · Cited by 186
Moore, R. E., Smith, C. K., Bailey, C. S., Voelkel, E. F., & Tashjian, A. H. (1993) · Bone and Mineral · doi:10.1016/s0169-6009(08)80105-5 · Cited by 178
Bone Changes and Carotid Atherosclerosis in Postmenopausal Women
Uyama, O., Yoshimoto, Y., Yamamoto, Y., & Kawai, A. (1997) · Stroke · doi:10.1161/01.str.28.9.1730 · Cited by 177
Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels.
Pennisi, P., Signorelli, S. S., Riccobene, S., Celotta, G., Di Pino, L., La Malfa, T., & Fiore, C. E. (2004) · Osteoporosis International · doi:10.1007/s00198-003-1550-9 · Cited by 160
Takeuchi, T., Tsuboi, T., Arai, M., & Togari, A. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00591-8 · Cited by 151
Hatton, R., Stimpel, M., & Chambers, T. J. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1520005 · Cited by 133
Bone mineral density in women with essential hypertension
Tsuda, K., Nishio, I., & Masuyama, Y. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)01303-6 · Cited by 133
Descriptive tools and analysis.
Capellà, D. (1993) · PubMed · Cited by 127
Fracture Risk in Perimenopausal Women Treated with Beta-Blockers
Rejnmark, L., Vestergaard, P., Kassem, M. S., Rud, B., Kolthoff, N., Brixen, K., & Mosekilde, L. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0222-x · Cited by 117
Self-citationEffects of propranolol on bone metabolism in the rat
Minkowitz, B., Boskey, A. L., Lane, J. M., Pearlman, H. S., & Vigorita, V. J. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090613 · Cited by 107
Bone remodeling signaled by a dihydropyridine- and phenylalkylamine-sensitive calcium channel.
Guggino, S. E., Lajeunesse, D., Wagner, J. A., & Snyder, S. H. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2957 · Cited by 102
Akatsu, T., Takahashi, N., Udagawa, N., Sato, K., Nagata, N., Moseley, J. M., Martin, T. J., & Suda, T. (1989) · Endocrinology · doi:10.1210/endo-125-1-20 · Cited by 95
Nielsen, G. L., Sørensen, H. T., Zhou, W., Steffensen, F. H., & Olsen, J. (1997) · International Journal of Risk and Safety in Medicine · doi:10.3233/jrs-1997-10309 · Cited by 89
Hiruma, Y., Inoue, A., Hirose, S., & Hagiwara, H. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.5914 · Cited by 82
PEREZCASTRILLON, J. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00845-8 · Cited by 77
Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems
Grant, F. D. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.4.988 · Cited by 76
Effects of Various Antihypertensive Drugs on the Function of Osteoblast.
NISHIYA, Y., & SUGIMOTO, S. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.628 · Cited by 48
Pérez‐Castrillón, J. L., Justo, I., Silva, J., Sanz, A., Martín-Escudero, J. C., Igea, R., Escudero, P., Pueyo, C., Díaz-Jullien, C., Hernández, G., et al. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)03263-6 · Cited by 31
Albers, M., Johnson, W., Vivian, V. M., & Jackson, R. D. (1991) · Bone · doi:10.1016/8756-3282(91)90053-l · Cited by 27
Effects of β‐adrenergic blockade in an osteoblast‐like cell line
Majeska, R. J., Minkowitz, B., Bastian, W., & Einhorn, T. A. (1992) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100100310 · Cited by 27
Mosekilde, L., Jastrup, B., Melsen, F., Lund, B., Lund, B., Sørensen, O. H., Nielsen, H. E., & Yde, H. (1984) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1984.tb02095.x · Cited by 22
Self-citationAlbumin Excretion Rate and Metabolic Modifications in Patients With Essential Hypertension
Puig, J. G., Mateos, F., Ramos, T. H., Lavilla, M. P., Capitán, M. C., & Gil, A. (1994) · American Journal of Hypertension · doi:10.1093/ajh/7.1.46 · Cited by 19
Verapamil increases serum alkaline phosphatase in hypertensive patients
Sjödén, G., Rosenqvist, M. A., Kriegholm, E., Nordenström, J., & Björkhem, I. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00242.x · Cited by 12
Calcium absorption and excretion in patients treated with verapamil.
Sjoden, G., Rosenqvist, M. A., Kriegholm, E., & Haglund, K. (1987) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1987.tb03182.x · Cited by 9
Cited by
Buford, T. W. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.01.007 · Cited by 561
Convergence between bone and energy homeostases: Leptin regulation of bone mass
Karsenty, G. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.10.008 · Cited by 418
Angiotensin II accelerates osteoporosis by activating osteoclasts
Shimizu, H., Nakagami, H., Osako, M. K., Hanayama, R., Kunugiza, Y., Kizawa, T., Tomita, T., Yoshikawa, H., Ogihara, T., & Morishita, R. (2008) · The FASEB Journal · doi:10.1096/fj.07-098954 · Cited by 294
“Recent clinical studies also support the benefit of ACE inhibitors to reduce risk of fractures or improve bone metabolism (6, 7 ). These data suggest that the renin-angiotensin system might be involved in bone metabolism.”
ResultVestergaard, P., Rejnmark, L., & Mosekilde, L. (2009) · Calcified Tissue International · doi:10.1007/s00223-008-9195-5 · Cited by 283
Self-citationRegulation of bone remodeling by the central and peripheral nervous system
Elefteriou, F. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.016 · Cited by 229
Metadata
- Authors
- Rejnmark, L., Vestergaard, P., & Mosekilde, L.
- Venue
- Journal of Hypertension
- Published
- 2006-03
- Volume
- 24
- Issue
- 3
- Pages
- 581-589
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W2034121143
- Cited by
- 229
- References
- 35
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.